|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in china,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zeng H, Zuo T,
Xia C, Yang Z and He J: Cancer incidence and mortality in china in
2013: An analysis based on urbanization level. Chin J Cancer Res.
29:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Di J, Rutherford S and Chu C: Review of
the cervical cancer burden and population-based cervical cancer
screening in China. Asian Pac J Cancer Prev. 16:7401–7407. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang W, Chu HJ, Liang YC, Huang JM, Shang
CL, Tan H, Liu D, Zhao YH, Liu TY and Yao SZ: FABP5 correlates with
poor prognosis and promotes tumor cell growth and metastasis in
cervical cancer. Tumour Biol. 37:14873–14883. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z, Yang Y, Gao Y, Wu X, Yang X, Zhu Y,
Yang H, Wu L, Yang C and Song L: Elevated expression of flotillin-1
is associated with lymph node metastasis and poor prognosis in
early-stage cervical cancer. Am J Cancer Res. 6:38–50.
2015.PubMed/NCBI
|
|
6
|
Claussen C, Rausch AV, Lezius S,
Amirkhosravi A, Davila M, Francis JL, Hisada YM, Mackman N,
Bokemeyer C, Schmalfeldt B, et al: Microvesicle-associated tissue
factor procoagulant activity for the preoperative diagnosis of
ovarian cancer. Thromb Res. 141:39–48. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Otero LL, Alonso DF, Castro M, Cinat G,
Gabri MR and Gomez DE: Tissue factor as a novel marker for
detection of circulating cancer cells. Biomarkers. 16:58–64. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu YJ, Hou XD and Li YM: Effect of tissue
factor knockdown on the growth, invasion, chemoresistance and
apoptosis of human gastric cancer cells. Exp Ther Med. 7:1376–1382.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu Y, Qin X, Zhou J, Tu Z, Bi X, Li W, Fan
X and Zhang Y: Tissue factor pathway inhibitor-2 inhibits the
growth and invasion of hepatocellular carcinoma cells and is
inactivated in human hepatocellular carcinoma. Oncol Lett.
2:779–783. 2011.PubMed/NCBI
|
|
10
|
Geddings JE, Hisada Y, Boulaftali Y, Getz
TM, Whelihan M, Fuentes R, Dee R, Cooley BC, Key NS, Wolberg AS, et
al: Tissue factor-positive tumor microvesicles activate platelets
and enhance thrombosis in mice. J Thromb Haemost. 14:153–166. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eisenreich A, Bolbrinker J and Leppert U:
Tissue factor: A conventional or alternative target in cancer
therapy. Clin Chem. 62:563–570. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, You L, Chen J and Mao C:
Expression of kinesin family member 3B is associated with poor
prognosis in epithelial ovarian cancer patients. Int J Clin Exp
Pathol. 10:2834–2842. 2017.
|
|
13
|
Kasthuri RS, Taubman MB and Mackman N:
Role of tissue factor in cancer. J Clin Oncol. 27:4834–4838. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Unruh D, Sagin F, Adam M, Van Dreden P,
Woodhams BJ, Hart K, Lindsell CJ, Ahmad SA and Bogdanov VY: Levels
of alternatively spliced tissue factor in the plasma of patients
with pancreatic cancer may help predict aggressive tumor phenotype.
Ann Surg Oncol. 3 Suppl 22:S1206–S1211. 2015. View Article : Google Scholar
|
|
15
|
Cocco E, Varughese J, Buza N, Bellone S,
Lin KY, Bellone M, Todeschini P, Silasi DA, Azodi M, Schwartz PE,
et al: Tissue factor expression in ovarian cancer: Implications for
immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein
targeting tissue factor. Clin Exp Metastasis. 28:689–700. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lo L, Valentine H, Harrison J, Hayes S,
Welch I, Pritchard S, West C and Ang Y: Tissue factor expression in
the metaplasia–adenoma-carcinoma sequence of gastric cancer in a
european population. Br J Cancer. 107:1125–1130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schaffner F, Versteeg HH, Schillert A,
Yokota N, Petersen LC, Mueller BM and Ruf W: Cooperation of tissue
factor cytoplasmic domain and PAR2 signaling in breast cancer
development. Blood. 116:6106–6113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Golino P, Ragni M, Cimmino G and Forte L:
Role of tissue factor pathway inhibitor in the regulation of tissue
factor-dependent blood coagulation. Cardiovasc Drug Rev. 20:67–80.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mego M, Karaba M, Minarik G, Benca J,
Sedlácková T, Tothova L, Vlkova B, Cierna Z, Janega P, Luha J, et
al: Relationship between circulating tumor cells, blood
coagulation, and urokinase-plasminogen-activator system in early
breast cancer patients. Breast J. 21:155–160. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koizume S, Jin MS, Miyagi E, Hirahara F,
Nakamura Y, Piao JH, Asai A, Yoshida A, Tsuchiya E, Ruf W and
Miyagi Y: Activation of cancer cell migration and invasion by
ectopic synthesis of coagulation factor VII. Cancer Res.
66:9453–9460. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ma YY, He XJ, Wang HJ, Xia YJ, Wang SL, Ye
ZY and Tao HQ: Interaction of coagulation factors and
tumor-associated macrophages mediates migration and invasion of
gastric cancer. Cancer Sci. 102:336–342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li W, Xu S, Lin S and Zhao W:
Overexpression of runt-related transcription factor-2 is associated
with advanced tumor progression and poor prognosis in epithelial
ovarian cancer. J Biomed Biotechnol. 2012:4565342012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chanakira A, Westmark PR, Ong IM and
Sheehan JP: Tissue factor-factor VIIa complex triggers protease
activated receptor 2-dependent growth factor release and migration
in ovarian cancer. Gynecol Oncol. 145:167–175. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ribeiro FS, Simão TA, Amoêdo ND, Andreollo
NA, Lopes LR, Acatauassu R, Rumjanek FD, Albano RM, Pinto LF and
Monteiro RQ: Evidence for increased expression of tissue factor and
protease-activated receptor-1 in human esophageal cancer. Oncol
Rep. 21:1599–1604. 2009.PubMed/NCBI
|
|
25
|
Luan L, Yang Z and Tan J: Tissue factor
and circulating tumor cells. Tumor. 35(5)2015.
|
|
26
|
Yang HP, Yue L, Jiang WW, Liu Q, Kou JP
and Yu BY: Diosgenin inhibits tumor necrosis factor-induced tissue
factor activity and expression in THP-1 cells via down-regulation
of the NF-κB, Akt, and MAPK signaling pathways. Chin J Nat Med.
11:608–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
